NG9:FRA
NeoGenomics, Inc.
€13.86
arrow_downward
-3.38%(-0.49) 1D
Aug 25, 8:00:10 AM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NG9...
Open
€13.86
High
€13.86
Low
€13.86
Mkt. cap
2.16B
Avg. vol.
1.00
Volume
0.00
52-wk high
€14.24
52-wk low
€5.50
No. of employees
2K
Open
€13.86
High
€13.86
Low
€13.86
Mkt. cap
2.16B
Avg. vol.
1.00
Volume
0.00
52-wk high
€14.24
52-wk low
€5.50
No. of employees
2K
News stories
From web sources and news partners
Simply Wall Street
·
7 minutes ago
Court Win Over Natera Patents Could Be A Game Changer For NeoGenomics’ (NEO) RaDaR ST
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees2.5K
Founded2002
HeadquartersFort Myers, Florida, United States
SectorHealth care provider
Websiteneogenomics.com
AI content may include mistakes. Learn more